US Stock MarketDetailed Quotes

CTOR Citius Oncology

Watchlist
  • 0.7169
  • +0.0268+3.88%
Close Apr 7 16:00 ET
  • 0.6600
  • -0.0569-7.94%
Post 17:38 ET
51.30MMarket Cap-2.22P/E (TTM)

About Citius Oncology Company

Citius Oncology, Inc. is a pharmaceutical company, which engages in developing and commercializing targeted oncology therapies. Its lead product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent CTCL, a rare form of non-Hodgkin lymphoma. The company was founded on March 1, 2021 and is headquartered in Cranford, NJ.

Company Profile

SymbolCTOR
Company NameCitius Oncology
Listing DateDec 8, 2022
Founded2021
CEOMr. Leonard L. Mazur
MarketNASDAQ
Fiscal Year Ends09-30
Address11 Commerce Drive,1st floor
CityCranford
ProvinceNew Jersey
CountryUnited States of America
Zip Code07016
Websitehttps://www.citiusonc.com

Company Executives

  • Name
  • Position
  • Salary
  • Leonard L. Mazur
  • Chairman of the Board and Chief Executive Officer
  • --
  • Jaime Bartushak
  • Chief Financial Officer, Principal Accounting Officer and Treasurer
  • --
  • Dr. Myron Czuczman, M.D.
  • Chief Medical Officer and President
  • --
  • Myron Z. Holubiak
  • Director and Secretary
  • --
  • Carol Webb
  • Independent Director
  • --
  • Suren G. Dutia
  • Independent Director
  • --
  • Robert J. Smith
  • Independent Director
  • --
  • Joel D. Mayersohn
  • Independent Director
  • --
  • Dennis M. McGrath, C.P.A.
  • Independent Director
  • --
  • Dr. Eugene Holuka
  • Independent Director
  • --

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Dorian LPG
LPG
19.240
New Fortress Energy
NFE
5.740
Lantheus
LNTH
95.450
4
DexCom
DXCM
61.630
5
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
10.960
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings